The Federal Government has extended the administration of the second dose of the COVID19 vaccine from the 25th of June, to the 5th of July 2021.
The Executive Director, National Primary Healthcare Development Agency, DR.Faisal Shuaibu stated this in Abuja, at the weekly media briefing on COVID19 Vaccination Update.
Dr. Shauibu who said the extension became necessary due to different constraints arising from various economic and social engagements of those involved called on those yet to receive their second dose to do so before the windows of opportunity closes.
You would recall that the initial closing date for second dose administration was the 25th of June, 2021. Even though we have extended the timeline for the second dose administration until the 5th of July 2021, however those who have received their first dose no later than May 13th are advised to visit the nearest vaccination site to receive their second dose as soon as possible, for full protection against COVID-19.
The NPHCDA Executive Director noted that recent data shows that 2,099,568 people have been vaccinated with their first doses while 1,005,234 have received their second doses of the Oxford/AstraZeneca COVID-19 vaccine.
“You would recall that the government reopened administration of the first dose to address the increase in vaccine demand by people who were yet to be vaccinated at all. This resulted in the increase in the number of clients vaccinated with the first doses.”
Dr. Faisal Shuaib again said full vaccination does not exempt people who have received their second doses of the vaccine from observing the infection prevention and control measures.
“It is very important for everyone, including those who have received their second doses to continue to wear face masks and observe other non-pharmaceutical measures to prevent the spread of the virus.”
He urged Nigerians to continue to wear face masks and observe other non-pharmaceutical measures to prevent the spread of the virus.
Dr. Shuaibu who said Nigeria had not recorded any case of death directly linked to COVID-19 vaccination, noted that Cases of mild, moderate, and severe reactions that have been recorded are expected from normal vaccination.
He said people who experienced any of these side effects have since recovered and are doing well.
“Therefore, we should not allow the fear of side effects to discourage us from taking the vaccine, as the long term benefits of getting vaccinated far outweighs the risk of brief side effects.”